We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Increased Oximetry Monitoring for Postsurgical Patients

By HospiMedica staff writers
Posted on 11 Nov 2003
Continuous pulse oximetry monitoring of high-risk postsurgical patients on the general care floor for 24 hours following surgery is important for detecting hypoxemia, according to two studies presented at the annual meeting of the American Society of Anesthesiologists in San Francisco (CA, USA).

The studies were conducted to test several common perceptions about postoperative hypoxemia. More...
One perception was that patients who receive patient-controlled narcotic analgesics alone following surgery are at less risk for respiratory depression and postoperative hypoxemia than patients who receive intrathecal morphine or both strategies simultaneously. The other perception was that patients with major peripheral surgery treated with either patient-controlled narcotics or intrathecal morphine are less at risk for hypoxemia compared with midline abdominal surgery patients receiving similar analgesics.

After continuous pulse oximetry monitoring of patients on the general care floor for the 24 hours following surgery, the researchers concluded that all types of narcotic analgesic strategies used, regardless of the type of surgery performed, have a significant impact on a patient's risk for postoperative hypoxemia. The prevalence of postoperative hypoxemia was extremely high across all patient groups due to the use of narcotic analgesics. The oximetry monitoring system used in the study was the Oxinet II Central Station Network from Nellcor (Pleasanton, CA, USA).

"Through our research, we have found that any use of narcotics in postoperative pain management places patients at increased risk for hypoxemia and significant respiratory depression,” said J. Paul Curry, M.D., department of anesthesiology, Hoag Memorial Hospital Presbyterian, Newport Beach (CA, USA).





Related Links:
Nellcor
oag Memorial Hospital Presbyterian

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.